Zhejiang Wolwo Bio-Pharmaceutical

Zhejiang Wolwo Bio-Pharmaceutical is one of the...

• CSI 500.

Zhejiang Wolwo Bio-Pharmaceutical is a company listed under the stock ticker 300357 (CN).

View the org chart displaying its 8 main executives

Most searched biographies at Zhejiang Wolwo Bio-Pharmaceutical

• Gengxi Hu, Chairman of The Board, General Manager and Acting Secre...
• Guoliang Xu, Independent Director
• Lu Zhang, Director

Create your alert
to follow the executive moves at Zhejiang Wolwo Bio-Pharmaceutical.

Zhejiang Wolwo Bio-Pharmaceutical has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Zhejiang Wolwo Bio-Pharmaceutical

Social media about Zhejiang Wolwo Bio-Pharmaceutical

• Zhejiang Wolwo Bio-Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Zhejiang Wolwo Bio-Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Gengxi Hu

Call Zhejiang Wolwo Bio-Pharmaceutical at +86 572...

View the org chart

Register to receive your alert

Report an error